How AI Fixes Broken Clinical Trials & Empowers Cancer Patients - Adam Blum
Why do only 3% ofcancer patients ever access clinical trials when advanced trials oftenrepresent superior care, and how is generative AI solving the unstructured datacrisis that prevents patients from accessing life-saving treatments?
Adam Blum is a veteran technologist, softwarearchitect, cancer survivor, and the founder of CancerBot—anon-profit AI platform designed to make precision clinical trial matchingaccessible and free for everyone. While on an intense cycling expedition acrossthe French Alps, Adam experienced sudden, debilitating exhaustion, culminatingin an unexpected diagnosis of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.